GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Hubei Biocause Pharmaceutical Co Ltd (SZSE:000627) » Definitions » 3-Year Book Growth Rate

Hubei Biocause Pharmaceutical Co (SZSE:000627) 3-Year Book Growth Rate : -0.90% (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Hubei Biocause Pharmaceutical Co 3-Year Book Growth Rate?

Hubei Biocause Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥4.16.

During the past 12 months, Hubei Biocause Pharmaceutical Co's average Book Value per Share Growth Rate was -5.50% per year. During the past 3 years, the average Book Value per Share Growth Rate was -0.90% per year. During the past 5 years, the average Book Value per Share Growth Rate was 1.40% per year. During the past 10 years, the average Book Value per Share Growth Rate was 16.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Hubei Biocause Pharmaceutical Co was 54.10% per year. The lowest was -4.50% per year. And the median was 9.70% per year.


Competitive Comparison of Hubei Biocause Pharmaceutical Co's 3-Year Book Growth Rate

For the Insurance - Life subindustry, Hubei Biocause Pharmaceutical Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hubei Biocause Pharmaceutical Co's 3-Year Book Growth Rate Distribution in the Insurance Industry

For the Insurance industry and Financial Services sector, Hubei Biocause Pharmaceutical Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Hubei Biocause Pharmaceutical Co's 3-Year Book Growth Rate falls into.



Hubei Biocause Pharmaceutical Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


Hubei Biocause Pharmaceutical Co  (SZSE:000627) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Hubei Biocause Pharmaceutical Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Hubei Biocause Pharmaceutical Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Hubei Biocause Pharmaceutical Co (SZSE:000627) Business Description

Traded in Other Exchanges
N/A
Address
2nd Floor, Building 1, No. 1 Tianshan Road, Guohua Huijin Center, Zhanghe New District, Hubei Province, Jingmen, CHN, 448000
Hubei Biocause Pharmaceutical Co Ltd is a China-based company engaged in life insurance, health insurance, accident insurance, and other life insurance businesses, medicine, and chemical businesses. The company generates its revenue in the form of premiums.
Executives
Jiang Hai Hua Independent director
Fu Yong Jin Directors, executives
Wu Shi Yan Supervisors

Hubei Biocause Pharmaceutical Co (SZSE:000627) Headlines

No Headlines